Patent ID: 6632428
Filing Date: 2003-10-14
Classification: A23L,A61K,A61P,C12N,C12R,Y10S

Abstract:
A composition for treating elevated above normal serum cholesterol and/or triglycerides, said composition comprising:a solid, impure residue separated from the fermentation broth of fermentation of the strain or mixtures of a strain of Monascus, said residue containing at least about 0.05% lovastatin by weight, and a pharmaceutically acceptable carrier, wherein said Monascus strain comprises a strain selected from the group consisting of Monascus albidus Sato AS 3.570, AS 3.4440, CGMCC No. 0317; Monascus pilosus Sato AS 3.4444, AS 3.4633, AS 3.4646, AS 3.4647; Monascus pubigerus Sato AS 3.4445, Monascus ruber van Tieghem AS 3.549, CGMCC No. 0315, CGMCC No. 0316; Monascus paxii Lingelsheim AS 3.4453; Monascus fuliginosus Sato AS 3.569, AS 3.1098, AS 3.2091, AS 3.2093, AS 3.2134, IFFI 05035, and Monascus purpureus Went CGMCC No. 0272.